Seguir
de la Fuente-Sandoval C
de la Fuente-Sandoval C
Instituto Nacional de Neurología y Neurocirugía
Dirección de correo verificada de unam.mx
Título
Citado por
Citado por
Año
Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis
P León-Ortiz, R Favila, S Stephano, D Mamo, J Ramírez-Bermúdez, ...
Neuropsychopharmacology 36 (9), 1781-1791, 2011
2532011
Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance …
C de la Fuente-Sandoval, P León-Ortiz, M Azcárraga, S Stephano, ...
JAMA psychiatry 70 (10), 1057-1066, 2013
1852013
Glutamate-mediated excitotoxicity in schizophrenia: a review
E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ...
European Neuropsychopharmacology 24 (10), 1591-1605, 2014
1722014
Cortico-striatal GABAergic and glutamatergic dysregulations in subjects at ultra-high risk for psychosis investigated with proton magnetic resonance spectroscopy
C de la Fuente-Sandoval, F Reyes-Madrigal, X Mao, P León-Ortiz, ...
International Journal of Neuropsychopharmacology 19 (3), pyv105, 2016
992016
A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients
A Fresán, C De la Fuente-Sandoval, C Loyzaga, M Garcı́a-Anaya, ...
Schizophrenia Research 72 (2-3), 123-129, 2005
992005
Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: a proton magnetic resonance …
E Plitman, C de la Fuente-Sandoval, F Reyes-Madrigal, S Chavez, ...
Schizophrenia bulletin 42 (2), 415-424, 2016
972016
Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study
C de la Fuente-Sandoval, P León-Ortiz, M Azcárraga, R Favila, ...
International Journal of Neuropsychopharmacology 16 (2), 471-475, 2013
962013
Prefrontal and striatal gamma-aminobutyric acid levels and the effect of antipsychotic treatment in first-episode psychosis patients
C de la Fuente-Sandoval, F Reyes-Madrigal, X Mao, P León-Ortiz, ...
Biological psychiatry 83 (6), 475-483, 2018
742018
Violent behavior in schizophrenic patients: relationship with clinical symptoms
A Fresán, R Apiquian, C de la Fuente‐Sandoval, C Löyzaga, ...
Aggressive Behavior: Official Journal of the International Society for …, 2005
712005
Reduced P3a amplitudes in antipsychotic naive first-episode psychosis patients and individuals at clinical high-risk for psychosis
A Mondragón-Maya, R Solís-Vivanco, P León-Ortiz, Y Rodríguez-Agudelo, ...
Journal of psychiatric research 47 (6), 755-761, 2013
662013
Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study
JL Winterburn, AN Voineskos, GA Devenyi, E Plitman, ...
Schizophrenia research 214, 3-10, 2019
652019
Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: a mega-analysis of …
K Merritt, PK McGuire, A Egerton, A Aleman, W Block, OJN Bloemen, ...
JAMA psychiatry 78 (6), 667-681, 2021
582021
Frontal and limbic metabolic differences in subjects selected according to genetic variation of the SLC6A4 gene polymorphism
A Graff-Guerrero, C De la Fuente-Sandoval, B Camarena, ...
Neuroimage 25 (4), 1197-1204, 2005
582005
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies
T Nakahara, S Tsugawa, Y Noda, F Ueno, S Honda, M Kinjo, H Segawa, ...
Molecular Psychiatry 27 (1), 744-757, 2022
562022
Association of structural magnetic resonance imaging measures with psychosis onset in individuals at clinical high risk for developing psychosis: an ENIGMA working group mega …
M Jalbrzikowski, RA Hayes, SJ Wood, D Nordholm, JH Zhou, P Fusar-Poli, ...
JAMA psychiatry 78 (7), 753-766, 2021
562021
Glutamatergic metabolites, volume and cortical thickness in antipsychotic-naive patients with first-episode psychosis: implications for excitotoxicity
E Plitman, R Patel, JK Chung, J Pipitone, S Chavez, F Reyes-Madrigal, ...
Neuropsychopharmacology 41 (10), 2606-2613, 2016
562016
Personality features in ultra-high risk for psychosis: A comparative study with schizophrenia and control subjects using the Temperament and Character Inventory-Revised (TCI-R)
A Fresán, P León-Ortiz, R Robles-García, M Azcárraga, D Guizar, ...
Journal of psychiatric research 61, 168-173, 2015
492015
Cerebral blood flow changes associated with experimental pain stimulation in patients with major depression
A Graff-Guerrero, F Pellicer, Y Mendoza-Espinosa, P Martínez-Medina, ...
Journal of affective disorders 107 (1-3), 161-168, 2008
452008
Mismatch Negativity reduction in the left cortical regions in first-episode psychosis and in individuals at ultra high-risk for psychosis
R Solís-Vivanco, A Mondragón-Maya, P León-Ortiz, Y Rodríguez-Agudelo, ...
Schizophrenia Research 158 (1-3), 58-63, 2014
442014
Functional magnetic resonance imaging response to experimental pain in drug-free patients with schizophrenia
C De la Fuente-Sandoval, R Favila, D Gómez-Martin, F Pellicer, ...
Psychiatry Research: Neuroimaging 183 (2), 99-104, 2010
432010
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20